Hospira Japan

Hospira Japan was the Japanese subsidiary of Hospira, a global leader in injectable drugs and infusion technologies. The company specialized in the development and distribution of generic injectables, biosimilars, and medication management systems for hospital use. Following the global acquisition of Hospira by Pfizer in 2015, Hospira Japan's operations were integrated into Pfizer Japan to strengthen its sterile injectables and biosimilars business. The company was recognized for its portfolio in oncology, anti-infectives, and critical care, providing cost-effective therapeutic options to the Japanese healthcare system. Its legacy continues through the products and technologies now managed under the Pfizer and Viatris brands. The integration allowed for a broader reach of essential medicines across Japanese clinical settings.